These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29853342)

  • 41. [Therapy of atrial fibrillation with class III anti-arrhythmia agents].
    Follath F; Candinas R; Frielingsdorf J
    Herz; 1993 Feb; 18(1):20-6. PubMed ID: 8454249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sotalol: a new agent for the treatment of ventricular arrhythmias.
    Samoil D; Grubb BP; Temesy-Armos PN
    Am J Med Sci; 1994 Jan; 307(1):49-53. PubMed ID: 8291508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sotalol marketed for life-threatening arrhythmias.
    Clin Pharm; 1993 Mar; 12(3):176. PubMed ID: 8491074
    [No Abstract]   [Full Text] [Related]  

  • 44. [Sotahexal pharmacodynamics in patients with ischemic heart disease].
    Dorofeeva EIu; Gorshkov VA; Chestukhin VV; Lyskovtsev VV; Bezprozvannyĭ AB; Avdeĭchuk ED; Kesarev GV; Lazutina OM; Nesvetov VN; Radzevich AE
    Ter Arkh; 1997; 69(8):17-9. PubMed ID: 9381384
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significance of Supraventricular Tachyarrhythmias After Coronary Artery Bypass Graft Surgery and Their Prevention by Low-Dose Sotalol: A Prospective Double-Blind Randomized Placebo-Controlled Study.
    Weber UK; Osswald S; Buser P; Huber M; Skarvan K; Stulz P; Pfisterer M
    J Cardiovasc Pharmacol Ther; 1998 Jul; 3(3):209-216. PubMed ID: 10684499
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery.
    Nyström U; Edvardsson N; Berggren H; Pizzarelli GP; Rådegran K
    Thorac Cardiovasc Surg; 1993 Feb; 41(1):34-7. PubMed ID: 8103611
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sotalol.
    Hohnloser SH; Woosley RL
    N Engl J Med; 1994 Jul; 331(1):31-8. PubMed ID: 8202100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Iontophoresis for modulation of cardiac drug delivery in dogs.
    Labhasetwar V; Underwood T; Schwendeman SP; Levy RJ
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2612-6. PubMed ID: 7708693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
    Ho AT; Pai SM; Timothy P; Pai RG
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is class III antiarrhythmic activity important?
    Singh BN
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():597-602. PubMed ID: 2275889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Developing a safe intravenous sotalol dosing regimen.
    Somberg JC; Preston RA; Ranade V; Molnar J
    Am J Ther; 2010; 17(4):365-72. PubMed ID: 20562595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of intravenous sotalol on ventricular arrhythmias occurring during maximal exercise stress testing.
    Stroobandt R; Kesteloot H
    Arch Int Pharmacodyn Ther; 1983 Aug; 264(2):290-7. PubMed ID: 6639220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Sotalol and quinidine/verapamil (Cordichin) in chronic atrial fibrillation--conversion and 12-month follow-up--a randomized comparison].
    Kalusche D; Stockinger J; Betz P; Roskamm H
    Z Kardiol; 1994; 83 Suppl 5():109-16. PubMed ID: 7846939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
    Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concurrent supplement of estradiol and progesterone reduces the cardiac sensitivity to D,L-sotalol-induced arrhythmias in ovariectomized rabbits.
    Cheng J; Su D; Ma X; Li H
    J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):208-14. PubMed ID: 21875897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Sotalol--atrial fibrillation, reduced renal function and sudden death].
    Bathen J; Madsen S
    Tidsskr Nor Laegeforen; 1998 Oct; 118(26):4086-7. PubMed ID: 9844513
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Electrophysiologic effect of sotalol in supraventricular tachycardias].
    Borggrefe M; Breithardt G
    Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Model-Informed Development of Sotalol Loading and Dose Escalation Employing an Intravenous Infusion.
    Somberg JC; Vinks AA; Dong M; Molnar J
    Cardiol Res; 2020 Oct; 11(5):294-304. PubMed ID: 32849964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose-response effects of sotalol on cardiovascular function in conscious, freely moving cynomolgus monkeys.
    Lynch JJ; Wilson AW; Hernandez LE; Nelson RA; Marsh KC; Cox BF; Mittelstadt SW
    Br J Pharmacol; 2008 Aug; 154(7):1439-45. PubMed ID: 18516073
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemodynamic effects of intravenous and oral sotalol.
    Mahmarian JJ; Verani MS; Pratt CM
    Am J Cardiol; 1990 Jan; 65(2):28A-34A; discussion 35A-36A. PubMed ID: 2403732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.